Justices Reject J&J Bid to Save Patent Case

February 21, 2012, 10:58 am by Wall Street Journal

The U.S. Supreme Court refused to consider a J&J subsidiary's bid to save its patent lawsuit targeting Abbott Laboratories' treatment for rheumatoid arthritis.

Read the full article

More from Wall Street Journal

Human Genome Adopts Poison Pill
Wall Street Journal : May 17, 2012, 12:03 pm
Human Genome Sciences adopted a shareholder rights plan with a 15% trigger in the wake of Glaxo's $2.6 billion hostile takeover bid for the biotech firm.

FDA Approves Generic Versions of Plavix
Wall Street Journal : May 17, 2012, 3:39 am
The U.S. Food and Drug Administration on Thursday approved generic versions of blood-thinning drug Plavix.

Zytiga Can Eliminate Some Prostate Tumors
Wall Street Journal : May 16, 2012, 10:49 am
A study looking at small group of men with prostate cancer showed the use of Johnson & Johnson's Zytiga eliminated or greatly reduced the size of prostate tumors in one-third of patients

Federal Probe of Medtronic Ends
Wall Street Journal : May 16, 2012, 9:34 am
A federal probe into Medtronic's marketing of a bone-graft product, Infuse, is over, the company said.

Bid to Coax States on Health Exchanges
Wall Street Journal : May 16, 2012, 9:19 am
The Obama administration on Wednesday made a fresh bid to coax reluctant governors to work with the federal government to help enact the health-overhaul law.